https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-09-11 / Oncoimmunology 2016 Feb;5(2):e1083669
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-09-11 / Oncoimmunology 2016 Feb;5(2):e10836692015-09-11 00:00:002021-11-15 13:26:23Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-09-10 / Bioimpacts 2015;5(3):117-22
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-09-10 / Bioimpacts 2015;5(3):117-222015-09-10 00:00:002019-02-15 08:46:12A prospective highlight on exosomal nanoshuttles and cancer immunotherapy and vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-09-04 / Prog Tumor Res 2015;42:11-21
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-09-04 / Prog Tumor Res 2015;42:11-212015-09-04 00:00:002019-02-15 08:34:50Immunotherapy of Brain Tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-09-01 / PLoS ONE 2015;10(9):e0136911
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-09-01 / PLoS ONE 2015;10(9):e01369112015-09-01 00:00:002019-02-15 08:49:38Prophylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-08-27 / J. Neurooncol. 2015 Oct;125(1):65-74
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-08-27 / J. Neurooncol. 2015 Oct;125(1):65-742015-08-27 00:00:002019-02-15 08:47:20Ex vivo generation of dendritic cells from cryopreserved, post-induction chemotherapy, mobilized leukapheresis from pediatric patients with medulloblastoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-08-13 / Clin Transl Oncol 2016 Jan;18(1):82-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-08-13 / Clin Transl Oncol 2016 Jan;18(1):82-72015-08-13 00:00:002015-08-13 00:00:00Prospective study of cyclophosphamide, thiotepa, carboplatin combined with adoptive DC-CIK followed by metronomic cyclophosphamide therapy as salvage treatment for triple negative metastatic breast cancers patients (aged <45)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-08-07 / J. Neurosurg. 2015 Oct;123(4):989-97
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-08-07 / J. Neurosurg. 2015 Oct;123(4):989-972015-08-07 00:00:002019-02-15 08:47:20Dendritic cell-based immunotherapy targeting Wilms‘ tumor 1 in patients with recurrent malignant glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-08-01 / Transl Oncol 2015 Aug;8(4):327-38
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-08-01 / Transl Oncol 2015 Aug;8(4):327-382015-08-01 00:00:002019-02-15 08:46:10Enhancement of the Immunostimulatory Functions of Ex Vivo-Generated Dendritic Cells from Early-Stage Colon Cancer Patients by Consecutive Exposure to Low Doses of Sequential-Kinetic-Activated IL-4 and IL-12. A Preliminary Study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-07-21 / J Immunother Cancer 2015;3:32
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-07-21 / J Immunother Cancer 2015;3:322015-07-21 00:00:002019-02-15 08:47:50Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-06-18 / Crit. Rev. Oncol. Hematol. 2015 Nov;96(2):339-54
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-06-18 / Crit. Rev. Oncol. Hematol. 2015 Nov;96(2):339-542015-06-18 00:00:002019-02-15 08:51:18Vaccination of multiple myeloma: Current strategies and future prospects
